New Data Support Flexibility in Timing of Administration for Sanofi's Lyxumia®
Paris (ots/PRNewswire) - - Similar glucose lowering effect when once-daily Lyxumia is administered before breakfast or the main meal - Sanofi announced today the results of a 24-week Phase IIIb clinical study showing that Lyxumia(R) (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered either before breakfast or ...